Cargando…
Commentary: Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233663/ https://www.ncbi.nlm.nih.gov/pubmed/28133451 http://dx.doi.org/10.3389/fpsyt.2016.00210 |
| _version_ | 1782494873075580928 |
|---|---|
| author | Ruan, Xiulu Luo, Jin Jun Kaye, Alan David |
| author_facet | Ruan, Xiulu Luo, Jin Jun Kaye, Alan David |
| author_sort | Ruan, Xiulu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5233663 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-52336632017-01-27 Commentary: Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA Ruan, Xiulu Luo, Jin Jun Kaye, Alan David Front Psychiatry Psychiatry Frontiers Media S.A. 2017-01-13 /pmc/articles/PMC5233663/ /pubmed/28133451 http://dx.doi.org/10.3389/fpsyt.2016.00210 Text en Copyright © 2017 Ruan, Luo and Kaye. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Psychiatry Ruan, Xiulu Luo, Jin Jun Kaye, Alan David Commentary: Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA |
| title | Commentary: Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA |
| title_full | Commentary: Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA |
| title_fullStr | Commentary: Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA |
| title_full_unstemmed | Commentary: Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA |
| title_short | Commentary: Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA |
| title_sort | commentary: hypnotic medications and suicide: risk, mechanisms, mitigation, and the fda |
| topic | Psychiatry |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233663/ https://www.ncbi.nlm.nih.gov/pubmed/28133451 http://dx.doi.org/10.3389/fpsyt.2016.00210 |
| work_keys_str_mv | AT ruanxiulu commentaryhypnoticmedicationsandsuicideriskmechanismsmitigationandthefda AT luojinjun commentaryhypnoticmedicationsandsuicideriskmechanismsmitigationandthefda AT kayealandavid commentaryhypnoticmedicationsandsuicideriskmechanismsmitigationandthefda |